TL;DR: Hale is broader; Mito costs less.
| Spec | Hale | Mito Red Light | Notes |
|---|---|---|---|
| Wavelengths | RLPRO: 630, 650, 660, 670, 810, 830, 850, 1060 nm | MitoPRO+ Series: 630, 660, 830, 850 nm | Mito publishes a four-wavelength MitoPRO+ platform. Hale publishes eight RLPRO wavelengths. |
| Irradiance | RLPRO 1000: ≥160 mW/cm2; RLPRO 1200/2000: ≥197 mW/cm2 | MitoPRO 1500+: >170 / >68 mW/cm2 at 6 in, with Mito's two-methodology footnotes | Methodology matters. Compare distance and meter type before treating either number as equivalent. |
| Coverage area | RLPRO 1200: 184 x 42 cm; RLPRO 2000: 189 x 58 cm | MitoPRO 1500+: 12 in x 36 in panel | Mito's large single panel is slimmer; Hale's RLPRO 2000 is wider. |
| LED count | RLPRO 1200: 864 LEDs; RLPRO 2000: 1,152 LEDs | MitoPRO 1500+: 300 LED chips | LED count alone does not prove dose, but it helps explain coverage and density. |
| Certifications (Health Canada, FDA) | Health Canada Class II MDL #111226 for RLPRO 1200/2000; FDA Establishment Registered | Publishes FDA Class II Registered, ETL Certified, ISO 9001/14001 | For Canadian buyers, Hale's Health Canada licence is the bigger regulatory distinction. |
| Warranty | 3 years | 3 years | No advantage either way on the published warranty term. |
| Price | RLPRO 1200: $4,800 CAD; RLPRO 2000: $6,700 CAD | MitoPRO 1500+: $1,169 USD | Currency mismatch. Mito's single panel has a much lower entry price. |
Source checked: MitoPRO+ Series product page, https://mitoredlight.com/products/mitopro-series.
Wavelength and Irradiance Comparison
The practical Hale vs Mito Red Light decision starts with two measurable variables: spectrum and delivered power. Mito Red Light publishes the MitoPRO+ Series as a four-wavelength panel family using 630, 660, 830, and 850 nm. That is a sensible mix: two red wavelengths for more superficial tissue targets and two near-infrared wavelengths for deeper tissue. It covers the core red light therapy range many home users look for.
Hale RLPRO panels publish eight wavelengths: 630, 650, 660, 670, 810, 830, 850, and 1060 nm. The difference is not that four wavelengths are useless. The difference is protocol flexibility. A clinic, sports facility, or serious home user may want 810 nm and 830 nm for common near-infrared protocols, 630 to 670 nm for skin and superficial tissue, and 1060 nm for deeper near-infrared coverage. If you only want the most common red/NIR pairings, Mito's narrower spectrum may be enough. If you want a single platform that covers more PBM protocol ranges, Hale has the broader published spectrum.
Irradiance is equally important because it determines how quickly a user can reach a target dose. Huang et al. described the biphasic dose response in photobiomodulation, where too little light may be ineffective and too much can reduce the desired effect [PMID:20011653]. That is why comparing only brand claims is weak. You need wavelength, distance, measurement method, treatment time, and target dose.
Mito publishes two irradiance figures for the MitoPRO 1500+ at 6 inches: >170 and >68 mW/cm2, with footnotes explaining different measurement methods. Hale publishes ≥197 mW/cm2 for the RLPRO 1200 and RLPRO 2000, and ≥160 mW/cm2 for the RLPRO 1000. The fair takeaway is that both brands publish high-output panel numbers, but the numbers should not be treated as interchangeable unless the meter, spectral isolation, and distance are aligned.
Certifications for Canadian Buyers
This is where Hale has a clearer, sourced difference. Hale RLPRO 1200 and RLPRO 2000 hold Health Canada Class II Medical Device Licence #111226. That does not mean every Hale product has the same status: RLPRO 1000 and Hale FACE are FDA-registered but are not Health Canada Class II devices. For the two larger RLPRO panels, though, the Health Canada licence is meaningful for Canadian clinics, physiotherapy settings, wellness centers, and buyers who want a device reviewed under Canada's medical device framework.
Mito publishes FDA Class II Registered, ETL Certified, and ISO 9001/14001 for the MitoPRO+ Series. Those are useful trust signals, especially for US buyers. The comparison is not that Mito has no certifications. The comparison is jurisdictional: if you are buying in Canada and specifically want a Health Canada Class II licensed red light therapy panel, Hale's RLPRO 1200 and 2000 have a published credential Mito does not publish on the product page checked.
Pricing, Warranty, and Price-per-mW
Mito's price advantage is real at the single-panel level. The sourced MitoPRO 1500+ product listing shows $1,169 USD for a 300-chip panel. Hale's comparable large-panel pricing is much higher in absolute dollars: $4,800 CAD for RLPRO 1200 and $6,700 CAD for RLPRO 2000. That price gap matters for home users who are trying to keep their first purchase under a lower budget.
A simple price-per-mW comparison is not clean here because the published irradiance numbers are not generated under identical methods and the currencies differ. It would be misleading to divide price by the headline irradiance and declare a winner. A better buyer method is to ask: how much coverage do you need, what wavelengths are required for the protocols you care about, and do you need Canadian medical device licensure?
Warranty is a draw on the published terms. Hale RLPRO panels carry a 3-year warranty, and Mito publishes a 3-year warranty for the MitoPRO+ Series. Support geography may still matter. Canadian buyers may prefer domestic Hale support; US buyers may prefer Mito's US brand presence.
Build Quality and Support
Both devices are metal-cased LED panels with fans, stands or mounting options, and published large-panel use cases. Mito's modular lineup can be attractive if you want to start with one panel and add another later. Hale's RLPRO 1200 and 2000 are more clinic-oriented from the start, with larger form factors, higher LED counts, and the Health Canada Class II credential for the larger models.
For a solo home user treating a single body side, Mito's smaller footprint can be a practical advantage. For a clinic that needs back-to-back sessions, broader body coverage, and Canadian documentation, Hale is easier to justify despite the higher initial purchase price.
Evidence Limits and Buyer Questions
The main limitation in this comparison is measurement comparability. Mito publishes helpful irradiance data, but it also publishes more than one number with methodology footnotes. Hale publishes its RLPRO figures as part of its own product specifications. Unless both brands publish the same distance, same spectral method, same meter type, same averaging area, and same test setup, the numbers should be treated as directional rather than perfectly interchangeable.
Buyers should ask both brands for the underlying test report if dose precision matters. Useful questions include: Was irradiance measured with a spectroradiometer or a broadband solar meter? Was the value averaged across the treatment area or taken at a central hotspot? Which wavelengths were active during the reading? How does output change at 12 inches or 18 inches? Those questions matter more than a single headline number.
The best evidence-backed decision is therefore practical. Mito is the lower-cost four-wavelength panel with published output data. Hale is the broader, more regulated Canadian panel platform with higher LED counts and Health Canada licensing on the larger RLPRO models. The right choice depends on whether the buyer is optimizing for budget, protocol breadth, or Canadian clinical documentation.
Use Case Recommendation
Choose Mito Red Light if budget is the main constraint, you are in the US, you want a straightforward four-wavelength panel, or you like the option to build a modular setup over time. Mito is also a reasonable fit if your protocols only require 630, 660, 830, and 850 nm and you do not need Health Canada Class II licensing.
Choose Hale if you want a broader eight-wavelength spectrum, a wider full-body panel option, and Health Canada Class II licensure on the RLPRO 1200 or 2000. Hale makes the most sense for Canadian practitioners, performance facilities, clinics, and serious home users who prefer one higher-spec platform over a lower-cost modular path.
Frequently Asked Questions
Is Hale or Mito Red Light better for full-body sessions?
Hale RLPRO 2000 has the wider published panel size and more LEDs, so it is stronger for broad single-position coverage. MitoPRO 1500+ costs less and can still cover large body areas, but its 12-inch width may require more repositioning.
Does Mito Red Light ship to Canada?
Mito's site supports Canadian browsing and checkout paths, but Canadian buyers should confirm shipping, taxes, duty, and warranty handling at checkout. Hale prices are already in CAD.
Is Mito Red Light FDA approved?
The checked Mito page publishes FDA Class II Registered. That is not the same wording as FDA approved. For LED wellness devices, buyers should be careful with the distinction between registration, clearance, and approval.
Which brand has better wavelengths?
Hale publishes more wavelengths. Mito publishes four useful wavelengths. Better depends on whether you need the broader protocol range or only the common red and near-infrared bands.
Which panel is cheaper?
MitoPRO 1500+ has the lower published entry price at $1,169 USD. Hale RLPRO panels cost more, starting from $3,900 CAD for RLPRO 1000 and $4,800 CAD for the Health Canada licensed RLPRO 1200.